← FDA DRUG APPROVALS

FDA ANDA · ANDA083345

POTASSIUM CHLORIDE

Sponsor: HOSPIRA

APPLICATION
ANDA083345
TYPE
ANDA
ORIGINAL APPROVAL
1974-02-13
LATEST ACTION
2002-12-11
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

POTASSIUM CHLORIDEDiscontinued
POTASSIUM CHLORIDE 2MEQ/ML · INJECTABLE · INJECTION
POTASSIUM CHLORIDEDiscontinued
POTASSIUM CHLORIDE 1MEQ/ML · INJECTABLE · INJECTION
POTASSIUM CHLORIDEDiscontinued
POTASSIUM CHLORIDE 1.5MEQ/ML · INJECTABLE · INJECTION

Approval history

2002-12-11Manufacturing (CMC) · Supplement 26AP
1994-08-12Labeling · Supplement 23AP
1992-06-02Labeling · Supplement 22AP
1991-11-07Labeling · Supplement 21AP
1989-08-23Labeling · Supplement 20AP
1985-08-29Manufacturing (CMC) · Supplement 19AP
1984-11-20Manufacturing (CMC) · Supplement 18AP
1974-02-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →